BioPharma Credit PLC (LON:BPCR)
London · Delayed Price · Currency is GBP · Price in USD 0.9420
+0.0120 (1.29%)
Mar 25, 2026, 4:35 PM GMT
BioPharma Credit Revenue
In the year 2025, BioPharma Credit had annual revenue of $157.75M USD with 5.14% growth. BioPharma Credit had revenue of $73.97M in the half year ending December 31, 2025, with 29.27% growth.
Revenue
$157.75M
Revenue Growth
+5.14%
P/S Ratio
6.69
Revenue / Employee
n/a
Employees
n/a
Market Cap
784.21M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 157.75M | 7.72M | 5.14% |
| Dec 31, 2024 | 150.03M | 14.29M | 10.53% |
| Dec 31, 2023 | 135.74M | -82.43M | -37.78% |
| Dec 31, 2022 | 218.17M | 114.29M | 110.02% |
| Dec 31, 2021 | 103.88M | -6.14M | -5.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jupiter Fund Management | 431.00M |
| The Law Debenture Corporation p.l.c. | 374.24M |
| Polar Capital Holdings | 228.77M |
| IntegraFin Holdings | 156.80M |
| Molten Ventures | 137.10M |
| Ashmore Group | 132.40M |
| Pollen Street Group | 127.94M |
| Oakley Capital Investments | 80.91M |